at 616 nm. In simulated body fluids (SBFs), the BGN-Eu demonstrated excellent bioactivity by inducing biological apatite mineralization. BGN-Eu also presented controlled drug (theophylline) loading ability and release behavior. The osteoblast (MC3T3) growth was significantly enhanced when incubated with different dosages of BGN-Eu, suggesting the high biocompatibility. In addition, BGN-Eu was successfully used to label the MC3T3 cell by a strong red fluorescence with low background noise. Our results suggest the great potential of BGN-Eu as multifunctional bioactive nanomaterials for cell imaging and bone tissue regeneration applications.
No takes yet. Share an insight, caveat, or question.
Xue et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: